The role of stress-response systems for the pathogenesis and progression of MS

被引:95
作者
Gold, SM
Mohr, DC
Huitinga, I
Flachenecker, P
Sternberg, EM
Heesen, C
机构
[1] Univ Hamburg, Hosp Eppendorf, Dept Neurol, D-20246 Hamburg, Germany
[2] Univ Calif Los Angeles, Sch Med, Dept Neurol, Multiple Sclerosis Program, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Sch Med, Ctr Psychoneuroimmunol, Neuropsychiat Inst, Los Angeles, CA 90095 USA
[4] Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Psychiat & Neurol, San Francisco, CA 94121 USA
[5] VUmc, Netherlands Inst Brain Res, NL-1105 AZ Amsterdam, Netherlands
[6] VUmc, MS Ctr, NL-1105 AZ Amsterdam, Netherlands
[7] Neurol Rehabil Zentrum Quellenhof, D-75323 Bad Wildbad, Germany
[8] NIMH, Integrat Neural Immune Program, Sect Neuroendocrine Immunol & Behav, NIH, Rockville, MD 20852 USA
关键词
D O I
10.1016/j.it.2005.09.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Disease progression in multiple sclerosis (MS) - an inflammatory demyelinating and neurodegenerative disease with a presumed T-cell driven autoimmune origin - has long been hypothesized to be associated with stress. However, this notion has only recently been supported by prospective clinical studies. Several clinical and molecular studies in MS and its animal models have recently shown disruptions in the communication between the immune system and the two major stress response systems, the hypothalamo-pituitary-adrenal (HPA) axis and the autonomic nervous system. Insensitivity to glucocorticoid and beta-adrenergic modulation might be involved in overshooting inflammation in MS, whereas hyperactivity of the HPA axis has been linked to neurodegeneration and increased disability. Here, we integrate findings from molecular, cellular, experimental, clinical and epidemiological research to describe the involvement of stress response systems in MS pathogenesis and progression.
引用
收藏
页码:644 / 652
页数:9
相关论文
共 70 条
[1]   More sympathy for autoimmunity with neuropeptide Y? [J].
Bedoui, S ;
Miyake, S ;
Straub, RH ;
von Hörsten, S ;
Yamamura, T .
TRENDS IN IMMUNOLOGY, 2004, 25 (10) :508-512
[2]   Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis [J].
Bergh, FT ;
Grasser, A ;
Trenkwalder, C ;
Backmund, H ;
Holsboer, F ;
Rupprecht, R .
JOURNAL OF NEUROLOGY, 1999, 246 (04) :292-298
[3]   Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS [J].
Bergh, FT ;
Kümpfel, T ;
Trenkwalder, C ;
Rupprecht, R ;
Holsboer, F .
NEUROLOGY, 1999, 53 (04) :772-777
[4]   Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences [J].
Bjartmar, C ;
Trapp, BD .
CURRENT OPINION IN NEUROLOGY, 2001, 14 (03) :271-278
[5]   PRAZOSIN, AN ALPHA-1-ADRENERGIC RECEPTOR ANTAGONIST, SUPPRESSES EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN THE LEWIS RAT [J].
BROSNAN, CF ;
GOLDMUNTZ, EA ;
CAMMER, W ;
FACTOR, SM ;
BLOOM, BR ;
NORTON, WT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (17) :5915-5919
[6]  
Charcot J.M., 1877, LECT DIS NERVOUS SYS
[7]   THE BETA-ADRENERGIC AGONIST ISOPROTERENOL SUPPRESSES EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN LEWIS RATS [J].
CHELMICKASCHORR, E ;
KWASNIEWSKI, MN ;
THOMAS, BE ;
ARNASON, BGW .
JOURNAL OF NEUROIMMUNOLOGY, 1989, 25 (2-3) :203-207
[8]   CHEMICAL SYMPATHECTOMY AUGMENTS THE SEVERITY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
CHELMICKASCHORR, E ;
CHECINSKI, M ;
ARNASON, BGW .
JOURNAL OF NEUROIMMUNOLOGY, 1988, 17 (04) :347-350
[9]   SYMPATHECTOMY AUGMENTS ADOPTIVELY TRANSFERRED EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
CHELMICKASCHORR, E ;
KWASNIEWSKI, MN ;
WOLLMANN, RL .
JOURNAL OF NEUROIMMUNOLOGY, 1992, 37 (1-2) :99-103
[10]   THE CONCEPTS OF STRESS AND STRESS SYSTEM DISORDERS - OVERVIEW OF PHYSICAL AND BEHAVIORAL HOMEOSTASIS [J].
CHROUSOS, GP ;
GOLD, PW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (09) :1244-1252